Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by BLVRA belongs to the biliverdin reductase family, members of which catalyze the conversion of biliverdin to bilirubin in the presence of NADPH or NADH. Additionally we are shipping Biliverdin Reductase Proteins (18) and Biliverdin Reductase Kits (15) and many more products for this protein.
Showing 10 out of 96 products:
Human Polyclonal Biliverdin Reductase Primary Antibody for ICC, IF - ABIN2482000
Singleton, Laster: Biliverdin reductase of guinea pig liver. in The Journal of biological chemistry 1970
Show all 3 references for 2482000
Human Polyclonal Biliverdin Reductase Primary Antibody for IP, IHC - ABIN2482106
Kutty, Maines: Purification and characterization of biliverdin reductase from rat liver. in The Journal of biological chemistry 1981
Show all 3 references for 2482106
Human Polyclonal Biliverdin Reductase Primary Antibody for ICC, IF - ABIN2482002
Mishra, Ndisang: A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes. in Current pharmaceutical design 2014
Show all 3 references for 2482002
Human Polyclonal Biliverdin Reductase Primary Antibody for WB - ABIN658292
Gibbs, Miralem, Maines: Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010
Show all 2 references for 658292
Human Polyclonal Biliverdin Reductase Primary Antibody for IHC, IHC (p) - ABIN4284633
Gromov, Espinoza, Talman, Honma, Kroman, Timmermans Wielenga, Moreira, Gromova: FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. in PLoS ONE 2014
Suggest that Gata-1 (show GATA1 Antibodies) and Nrf2a (show NFE2L2 Antibodies) play differential roles in regulating the heme degradation enzymes hmox1a/bvra/bvrb (show BLVRB Antibodies) during an early developmental period of heightened cellular stress
Genetic polymorphisms of the UGT1A1 (show UGT1A1 Antibodies) promoter, specifically the T-3279G phenobarbital-responsive enhancer module and (TA)7 dinucleotide repeat, as well as the intron and coding region variants of the OATP2 (show SLCO1B1 Antibodies), HMOX1 (show HMOX1 Antibodies), and BLVRA genes, were significantly higher among the cases than the controls.
BLVRA mRNA levels in the liver as well as in peripheral blood leukocytes are significantly higher in hepatocellular carcinoma patients most likely as a feedback mechanism to control increased oxidative stress associated with HCC (show FAM126A Antibodies) progression.
Data suggest that isoenzymes BVRA and BVRB (show BLVRB Antibodies) play different roles in energy metabolism and in pathogenesis of abdominal obesity and hypertriglyceridemia. [REVIEW]
Interactions of HO-2 (show HMOX2 Antibodies) with CPR (show POR Antibodies) and BVR, were evaluated.
Increased biliverdin reductase expression is associated with multidrug resistance in leukemia.
Our results suggest that patients with chronic HCV infection significantly upregulate BLVRA expression in PBL.
The current study reports increased levels of both HO-1 (show HMOX1 Antibodies) and BVR-A in plasma from probable Alzheimer disease patients, as a result of the increased oxidative environment.
rs699512 (Thr3Ala), the only common non-synonymous SNP within BLVRA, reduced the risk of essential hypertension in Kazaks.
A significant increase of nitrated BVRA was demonstrated only in Alzheimer's disease and mild cognitive impairment hippocampi
A homozygous BLVRA inactivating mutation is associated with the appearance of green jaundice accompanying cholestasis episodes.
These findings reveal a novel BVRA-GSKbeta-PPARalpha (show PPARA Antibodies) axis that regulates hepatic lipid metabolism and may provide unique targets for the treatment of non-alcoholic fatty liver disease.
BVR-A integrates both oxidative/nitrosative stress- and insulin (show INS Antibodies)-mediated signaling, both mechanisms dysregulated in the Alzheimer disease brain.
The biliverdin reductase A positive macrophage is a source of anti-inflammatory cytokine IL-10 (show IL10 Antibodies) in injured kidney.
Lack of p53 (show TP53 Antibodies) decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1 (show TXN Antibodies), biliverdin reductase-A, manganese superoxide dismutase (show SOD2 Antibodies), and nuclear factor kappa-B.
biliverdin reductase has a role in regulating the inflammatory response to endotoxin that requires eNOS (show NOS3 Antibodies)-derived NO and TLR4 (show TLR4 Antibodies) signaling in macrophages
biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt (show AKT1 Antibodies)
Inhibition of biliverdin reductase increases ANG II (show AGT Antibodies)-dependent superoxide levels in cultured renal tubular epithelial cells.
biliverdin reductase A (BLVRA) was identified as a partner of ELSPBP1 (show ELSPBP1 Antibodies) by immunoprecipitation followed by tandem mass spectrometry.
The protein encoded by this gene belongs to the biliverdin reductase family, members of which catalyze the conversion of biliverdin to bilirubin in the presence of NADPH or NADH. Mutations in this gene are associated with hyperbiliverdinemia. Alternatively spliced transcript variants have been found for this gene.
biliverdin reductase A
, biliverdin IX-beta reductase
, biliverdin reductase
, biliverdin reductase a
, BVR A
, biliverdin-IX alpha-reductase